Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone

References

• Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731–1740
   PubMed Web of Science ®Google Scholar
• Klostergaard J, Leroux ME, Tomasovic SP. Clonogenic survival studies of human colon tumor cell lines in vitro: Combined hyperthermia, 5-fluorouracil/leucovorin, carboplatin and tumor necrosis factor. Radiat Res 1995; 141: 44–48
   PubMedGoogle Scholar
• Klostergaard J, Leroux E, Siddik ZH, Khodadadian M, Tomasovic SP. Enhanced sensitivity of human colon tumor cell lines in vitro in response to thermochemoimmunotherapy. Cancer Res 1992; 52: 5271–5277
   PubMedGoogle Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119–1125
   PubMed Web of Science ®Google Scholar
• Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996; 35: 731–744
   PubMed Web of Science ®Google Scholar
• Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995; 345: 540–543
   Google Scholar
• Berdov BA, Menteshashvili GZ. Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia 1990; 6: 881–890
   PubMed Web of Science ®Google Scholar
• Berdov B, Kurpeshev OK, Mardinsky YSM. Influence of hyperthermia and hyperglycemia on efficiency radiation therapy for oncological patients. Russ J Oncol 1996; 20: 20
   Google Scholar
• Kakehi M, Ueda K, Mukojima T, Hiraoka M, Seto O, Akanuma A, et al. Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs. Int J Hyperthermia 1990; 6: 719–740
   PubMed Web of Science ®Google Scholar
• You QS, Wang RZ, Suen GQ, Yan FC, Gao YJ, Cui SR, et al. Combination preoperative radiation and endocavitary hyperthermia for rectal cancer: Long-term results of 44 patients. Int J Hyperthermia 1993; 9: 19–24
   PubMed Web of Science ®Google Scholar
• Trotter JM, Edis AJ, Blackwell JB, Lamb MH, Bayliss EJ, Shepherd JM, et al. Adjuvant VHF therapy in locally recurrent and primary unresectable rectal cancer. Australas Radiol 1996; 40: 298–305
   PubMedGoogle Scholar
• De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, Lutgens L, Lammering G, van Mastrigt GA, et al. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev 2009; 3: CD006269
   PubMed Web of Science ®Google Scholar
• Lagendijk JJ, Van Rhoon GC, Hornsleth SN, Wust P, De Leeuw AC, Schneider CJ, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia 1998; 14: 125–133
   PubMed Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005; 23: 3079–3085
   PubMed Web of Science ®Google Scholar
• Becker K, Mueller JD, Schulmacher C, Ott K, Fink U, Busch R, et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 2003; 98: 1521–1530
   PubMed Web of Science ®Google Scholar
• Schulze T, Wust P, Gellermann J, Hildebrandt B, Riess H, Felix R, et al. Influence of neoadjuvant radiochemotherapy combined with hyperthermia on the quality of life in rectum cancer patients. Int J Hyperthermia 2006; 22: 301–318
   PubMed Web of Science ®Google Scholar
• Bialas I, Bessell EM, Sokal M, Slack R. A prospective study of urinary tract infection during pelvic radiotherapy. Radiother Oncol 1989; 16: 305–309
   PubMedGoogle Scholar
• Velenik V, Ocvirk J, Oblak I, Anderluh F. A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer. Eur J Surg Oncol 2010; 36: 244–250
   PubMed Web of Science ®Google Scholar
• Velenik V, Ocvirk J, Music M, Bracko M, Anderluh F, Oblak I, et al. Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: Results of an open-label phase II study. Radiat Oncol 2011; 6: 105
   PubMed Web of Science ®Google Scholar
• Resch G, De Vries A, Ofner D, Eisterer W, Rabl H, Jagoditsch M, et al. Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer – A two stage phase II clinical trial. Radiother Oncol 2012; 102: 10–13
   PubMed Web of Science ®Google Scholar
• Aschele C, Cionini L, Lonardi S, Pinto C, Cordio S, Rosati G, et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 2011; 29: 2773–2780
   PubMed Web of Science ®Google Scholar
• Gerard JP, Azria D, Gourgou-Bourgade S, Martel-Laffay I, Hennequin C, Etienne PL, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010; 28: 1638–1644
   PubMed Web of Science ®Google Scholar
• Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005; 62: 752–760
   PubMed Web of Science ®Google Scholar
• Valentini V, Coco C, Picciocchi A, Morganti AG, Trodella L, Ciabattoni A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002; 53: 664–674
   PubMedGoogle Scholar
• Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, et al. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis. Int J Radiat Oncol Biol Phys 2006; 66: 1378–1383
   PubMed Web of Science ®Google Scholar
• Pucciarelli S, Toppan P, Friso ML, Russo V, Pasetto L, Urso E, et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 2004; 47: 1798–1807
   PubMed Web of Science ®Google Scholar
• Diaz-Gonzalez JA, Calvo FA, Cortes J, Garcia-Sabrido JL, Gomez-Espi M, Del Valle E, et al. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Int J Radiat Oncol Biol Phys 2006; 64: 1122–1128
   PubMed Web of Science ®Google Scholar
• Maas M, Nelemans PJ, Valentini V, Das P, Rodel C, Kuo LJ, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835–844
   PubMed Web of Science ®Google Scholar
• Maluta S, Romano M, Dall’oglio S, Genna M, Oliani C, Pioli F, et al. Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum. Int J Hyperthermia 2010; 26: 108–117
   PubMed Web of Science ®Google Scholar
• Gerard JP, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial. J Clin Oncol 2003; 21: 1119–1124
   PubMed Web of Science ®Google Scholar
• Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114–1123
   PubMed Web of Science ®Google Scholar
• Bujko K, Kolodziejczyk M. The 5 × 5 Gy with delayed surgery in non-resectable rectal cancer: A new treatment option. Radiother Oncol 2008; 87: 311–313
   PubMed Web of Science ®Google Scholar
• Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011; 29: 4633–4640
   PubMed Web of Science ®Google Scholar
• Rau B, Wust P, Hohenberger P, Loffel J, Hunerbein M, Below C, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: A phase II clinical trial. Ann Surg 1998; 227: 380–389
   PubMed Web of Science ®Google Scholar